Nephrology

Article	Citations
Intention to treat and per protocol analysis in clinical trials	99
Update on diagnosis, pathophysiology, and management of diabetic kidney disease	61
Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF‐PH inhibitors	55
Where to look for the most frequent biases?	49
Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time	35
Shear wave elastography accurately detects chronic changes in renal histopathology	28
Early predictors of acute kidney injury in COVID‐19 patients	26
Evidence‐based medicine—When observational studies are better than randomized controlled trials	26
Urinary exosomes: Potential biomarkers for diabetic nephropathy	26
Appraising prediction research: a guide and meta‐review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST)	24
Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances	23
Mediterranean diet and the risk of chronic kidney disease: A systematic review and meta‐analysis	22
Impact of COVID‐19 on maintenance haemodialysis patients: The Indian scenario	22
Posters	19
Humoral and cellular immune response to severe acute respiratory syndrome coronavirus‐2 vaccination in haemodialysis and kidney transplant patients	17
Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1‐S COVID‐19 vaccination: A case series of two patients	16
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE	16
Consequences of the first and secondCOVID‐19 wave on kidney transplant recipients at a large Indian transplant centre	15
Differential expression analysis of urinary exosomal circular RNAs in patients with IgA nephropathy	15
Dietary patterns and chronic kidney disease outcomes: A systematic review	15
Understanding the opposite effects of sex hormones in mediating renal injury	15
Effects of transient acute kidney injury, persistent acute kidney injury and acute kidney disease on the long‐term renal prognosis after an initial acute kidney injury event	14
Gross haematuria after mRNA COVID‐19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy	14
Methamphetamine intoxication and acute kidney injury: A prospective observational case series	13
Two decades of chronic kidney disease of unknown aetiology (CKDu) research: Existing evidence and persistent gaps from epidemiological studies in Sri Lanka	13

Influence of end stage renal disease on CD28 expression and T‐cell immunity	13
Report of two cases of minimal change disease following vaccination for COVID ‐19	13
Associations between nephrolithiasis and diabetes mellitus, hypertension and gallstones: A meta‐analysis of cohort studies	12
A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial	12
Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID‐19 in Mexico	12
A working partnership: A review of shared decision‐making in nephrology	12
Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta‐analysis	12
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact	12
Posters	12
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease – An Executive Summary	11
Funnel plots of patient‐reported outcomes to evaluate health‐care quality: Basic principles, pitfalls and considerations	11
The COVID‐19 pandemic and access to health care in people with chronic kidney disease: A systematic review and meta‐analysis	11
Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: A nationwide data linkage study (ANZACS‐QI 44)	11
Nodakenin alleviates renal ischaemia‐reperfusion injury via inhibiting reactive oxygen species‐induced NLRP3 inflammasome activation	11
Glomerular hyperfiltration in morbid obesity: Role of the inflammasome signalling	11
Sodium‐glucose cotransporter‐2 inhibitors and non‐steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin‐angiotensin system blockade	11
Renal supportive care, palliative care and end‐of‐life care: Perceptions of similarities, differences and challenges across Australia and New Zealand	11
Demographics and long‐term outcomes of children with end‐stage kidney disease: A 20‐year territory‐wide study	10
Advances in understanding the role of adiponectin in renal fibrosis	10
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates	10
De novo and relapsing glomerulonephritis after COVID‐19 vaccination: how much do we know?	10
Sodium‐glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidence	10
Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease	10
Gut microbiota, key to unlocking the door of diabetic kidney disease	10
Validation of non‐invasive transcutaneous measurement for glomerular filtration rate in lean and obese C57BL/6J mice	9
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors	9
Systemic complement activation in anti‐neutrophil cytoplasmic antibody‐associated vasculitis and necrotizing glomerulonephritis	9
Personalized immunosuppression after kidney transplantation	9
The burden of chronic kidney disease in Asia, 1990–2019: Examination of estimates from global burden of disease 2019 study	9
The case for increased peritoneal dialysis utilization in low‐ and lower‐middle‐income countries	9
Be careful with ecological associations	9
MiR‐1297 attenuates high glucose‐induced injury in HK‐2 cells via targeting COL1A2	8
Nicotiflorin attenuates cell apoptosis in renal ischemia‐reperfusion injury through activating transcription factor 3	8
A novel urine cell‐free DNA preservation solution and its application in kidney transplantation	8
Acute kidney injury associated with COVID‐19—Cumulative evidence and rationale supporting against direct kidney injury (infection)	8
Cognitive impairment, quality of life and healthcare utilization in patients with chronic kidney disease stages 3 to 5	8
Peritoneal dialysis: Status report in South and South East Asia	8
Levofloxacin based non‐rifampicin anti‐tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting	7
Case of “relapsing” COVID‐19 in a kidney transplant recipient	7
End stage renal disease has an early and continuous detrimental effect on regulatory T cells	7
Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single‐centre retrospective study in Beijing	7
Dietary interventions on the prevention and management of diabetes in post‐kidney transplantation – A systematic review	7
Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease	7
Aetiology, practice patterns and burden of end‐stage kidney disease in South Asia and South‐East Asia: A questionnaire‐based survey	7
Acute kidney injury in COVID‐19: Identification of risk factors and potential biomarkers of disease in a large UK cohort	7
Cardiorespiratory fitness assessed by cardiopulmonary exercise testing between different stages of pre‐dialysis chronic kidney disease: A systematic review and meta‐analysis	7
Predictors of technique failure and mortality on peritoneal dialysis: An analysis of New Zealand peritoneal dialysis registry data	7
Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy	7
Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients	7
Perspectives on blood pressure by patients on haemo‐ and peritoneal dialysis	7

Diastolic and systolic left ventricular dysfunction and mortality in chronic kidney disease patients on haemodialysis	7
Mycobacterium tuberculosis peritonitis in peritoneal dialysis patients: A scoping review	6
Effect of cumulative fluid balance on acute kidney injury and patient outcomes after orthotopic liver transplantation: A retrospective cohort study	6
Smad3 signalling affects high glucose‐induced podocyte injury via regulation of the cytoskeletal protein transgelin	6
Significant association of urinary alpha‐1‐microglobulin compared to urinary neutrophil gelatinase‐associated lipocalin with renal insufficiency in patients with type 2 diabetes	6
The kinetic estimated glomerular filtration rate ratio predicts acute kidney injury	6
Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort	6
Poster Presentations	6
Qualitative research methods and its application in nephrology	6
Anxiety and psychosocial impact during coronavirus disease 2019 in home dialysis patients	6
Immunoglobulin A nephropathy in paediatrics: An up‐to‐date	6
Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand	6
Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems	6
Urinary orosomucoid 1 protein to creatinine ratio as a potential biomarker for early screening of kidney impairment in type‐2 diabetes patients	6
Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy	6
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines	6
Determinants of volume status in peritoneal dialysis: A longitudinal study	6
Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006–2020	6
Changing landscape of dialysis withdrawal in patients with kidney failure: Implications for clinical practice	6
Recent research progress on the role of ulinastatin in chronic kidney disease	6
Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study	6
Reducingnon‐melanomaskin cancer risk in renal transplant recipients	5
Impact of imatinib treatment on renal function in chronic myeloid leukaemia patients	5
The use of virtual physician mentoring to enhance home dialysis knowledge and uptake	5
Exploring rural and remote patients' experiences of health services for kidney disease in Aotearoa New Zealand: An in‐depth interview study	5
Comparison of hospitalization outcomes for delivery and resource utilization between pregnant women with kidney transplants and chronic kidney disease in the United States	5
Severe hypocalcaemia following denosumab and iron infusion	5
Poster Presentations	5
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registry	5
Active deprescribing program in chronic kidney disease patients undergoing haemodialysis	5
Association between self‐reported appetite and clinical outcomes of peritoneal dialysis patients: Findings from a low middle‐income country	5
Lightning Talks	5
Clinical factors associated with early and persistent hypocalcaemia after parathyroidectomy in patients on dialysis with severe hyperparathyroidism	5
Traditional medicines prescribed for prevention of COVID‐19: Use with caution	5
Impact of pre‐transplant biopsy on 5‐year outcomes of expanded criteria donor kidney transplantation	5
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE – EXECUTIVE SUMMARY	5
Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine	5
Exit site infection and peritonitis due to Serratia species in patients receiving peritoneal dialysis: Epidemiology and clinical outcomes	5
Rituximab in maintaining remission in adults with podocytopathy	5
Clinical course of Immunoglobulin A nephropathy with crescents in a multi‐ethnic Southeast Asian cohort	5
Scutellarin protects the kidney from ischemia/reperfusion injury by targeting Nrf2	5
Serum electrolyte dynamics in multiple myeloma patients undergoing autologous haematopoietic stem cell transplantation	4
Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients	4
Comparison of skin cancer awareness and sun protection behaviours between renal transplant recipients and patients with glomerular disease treated with immunosuppressants	4
Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis	4
Impact of etelcalcetide on fibroblast growth factor‐23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis	4
Muscle power and physical dysfunction: A model for tailoring rehabilitation in chronic kidney disease	4
Clinical benefits of Tocilizumab in COVID‐19‐related cytokine release syndrome in a patient with end‐stage kidney disease on haemodialysis in Australia	4
Incremental peritoneal dialysis is a safe and feasible prescription in incident patients with preserved residual kidney function	4
Effect of remote patient management in peritoneal dialysis on haemodynamic and volume control	4
Performance of a pre‐procedural Mehran score to predict acute kidney injury after percutaneous coronary intervention	4
Safety and efficacy of Oxford vaccine in kidney transplant recipients: A single‐center prospective analysis from India	4
Regional variance in the use of urine dipstick test for outpatients in Japan	4
Renoprotection with sodium‐glucose cotransporter‐2 inhibitors in children: Knowns and unknowns	4
Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline	4
Spiritual well‐being and its relationship with patient characteristics and other patient‐reported outcomes in peritoneal dialysis patients: Findings from the PDOPPS	4
Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene	4
Histological diagnosis from kidney transplant biopsy can contribute to prediction of graft survival	4
The prevalence of chronic kidney disease in Samoans living in Auckland, New Zealand	4
The impact of age on patient tolerance of mycophenolate following kidney transplantation	4
Misclassification of calcium status in end‐stage kidney disease using albumin‐adjusted calcium levels	4
Magnetic resonance imaging determination of tissue sodium in patients with chronic kidney disease	4
COVID‐19 vaccine acceptance among patients with glomerulonephritis	4
From MIA to FIFA: The vicious matrix of frailty, inflammation, fluid overload and atherosclerosis in peritoneal dialysis	3
Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization	3
Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?	3
Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT‐2) trials	3
Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta‐analysis	3
Will advances in functional renal magnetic resonance imaging translate to the nephrology clinic?	3
Genetic insight into primary glomerulonephritis	3
Alport syndrome: Proteomic analysis identifies early molecular pathway alterations in Col4a3 knock out mice	3
Posters	3
Prognostic significance of carotid plaque presence in peritoneal dialysis patients and its association with the apolipoprotein B/apolipoprotein A1 ratio	3
Comparison of kidney transplant outcomes in HLA compatible and incompatible transplantation: A national cohort study	3
Potential determinants of the E/e′ ratio in non‐dialysis compared with dialysis patients	3
An outpatient model of care for COVID‐19 infected kidney transplant patients – The hospital‐at‐home	3
New‐onset immunoglobulin‐A nephropathy post severe acute respiratory syndrome‐coronavirus‐2 infection indicates rapidly progressive glomerulonephritis	3
Association of left ventricular hypertrophy and functional impairment with cardiovascular outcomes and mortality among patients with chronic kidney disease, results from the C‐STRIDE study	3
Associations of coenzyme Q10 with endothelial function in hemodialysis patients	3
Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease	3

Hepatitis B related dilemmas in the renal unit	3
The relationships among gut microbiota, hypoxia‐inducible factor and anaemia with chronic kidney disease	3
Systematic review and meta‐analysis of potential pleiotropic effects of sevelamer in chronic kidney disease: Beyond phosphate control	3
Stroke incidence and chronic kidney disease: A hospital‐based prospective cohort study	3
	3
The need for individualizing teaching and assurance of knowledge transmission to patients training for home dialysis	3
Prospective model for predicting renal recovery in cardiac surgery patients with acute kidney injury requiring renal replacement therapy	3
Profile of urinary exosomal microRNAs and their contribution to diabetic kidney disease through a predictive classification model	3
Role of lncRNA‐MEG8/miR‐296‐3p axis in gestational diabetes mellitus	3
Renal graft artery thrombosis following COVID‐19 infection	3
Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K/AKT/NF‐κB signalling pathway	3
Development of a novel AlphaLISA ImmunoAssay for Big angiotensin‐25	3
Implementation of artificial intelligence Chatbot in peritoneal dialysis nursing care: Experience from a Taiwan medical center	3
Impact of a kidney‐specific disease‐specific care certification program on the institutional performance indicators of hospitals caring for patients with chronic kidney disease: A national data analys	3
High prevalence of Afro‐Caribbean ethnicity and hypoglycaemia in patients with diabetes and end stage renal disease hospitalized with COVID‐19	3
Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease	3
COVID‐19 death and kidney disease in a multiracial Asian country	3